Buy, Sell or Hold? Goldman Sachs maintains a buy on Eternal; Citi recommends sell rating on Dr Reddy’s Laboratories post Q1 results

Goldman Sachs and Citi have issued fresh post-Q1 calls on three stocks. Goldman stays bullish on Eternal (Buy, target Rs 345, 21% upside) due to Blinkit's margin gains. Citi holds a Buy on JSW Energy (target Rs 650) despite EBITDA missing estimates, but maintains a Sell on Dr Reddy's, cutting the target to Rs 1,040 after a 69% profit fall.